Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-01-11, Stock:LLY, The news for the past five days is as follows:
2018-01-04: NEWS1: How Is Novo Nordisk’s New Generation Insulin Segment Positioned after 3Q17?.NEWS2: XLV, AMGN, GILD, LLY: Large Outflows Detected at ETF.NEWS3: Eli Lilly To Participate In Goldman Sachs Healthcare Conference At 8:00 AM ET.NEWS4: Eli Lilly To Participate In Goldman Sachs Healthcare Conference At 8:00 AM ET.
2018-01-05: NEWS1: A Look at Pfizer’s Valuation.NEWS2: Argus Shares Eli Lilly's Optimism, Upgrades To Buy.NEWS3: The Slow Push Upward Continues for Johnson & Johnson Stock.NEWS4: How Did Novo Nordisk’s Victoza and Saxendra Perform in 3Q17?.NEWS5: Lilly Confirms Date and Conference Call for Fourth-Quarter 2017 Financial Results Announcement.NEWS6: The Slow Push Upward Continues for Johnson & Johnson Stock.NEWS7: How Did Novo Nordisk’s Modern Insulin Segment Perform in 3Q17?.
2018-01-08: NEWS1: Eli Lilly CEO Says Tax Reform May Lead to More Successful Deals.NEWS2: Pfizer to Stall R&D for Alzheimer's/Parkinson's, Cut Jobs.NEWS3: Celgene deal could be the first of many for biopharma as new tax law frees up cash.NEWS4: Eli Lilly CEO: It's a great time for science in pharma se....NEWS5: Alzheimer's takes Another Hit as Pfizer Ends Research in this Area.NEWS6: Pfizer to Stall R&D for Alzheimer&apos;s/Parkinson&apos;s, Cut Jobs.NEWS7: Ozempic Could Boost Novo Nordisk’s Revenue Growth in 2018.NEWS8: Livongo and Lilly Collaborate on Real-World Diabetes Research.NEWS9: Alzheimer&apos;s takes Another Hit as Pfizer Ends Research in this Area.
2018-01-09: NEWS1: Ignyta’s Drug Pipeline.NEWS2: Health secretary nominee indicates support for Medicaid overhaul.NEWS3: Trump health pick wary of government drug price negotiations.NEWS4: Eli Lilly CEO on Drug Pricing and Diabetes Treatment.NEWS5: How Was Incyte’s Revenue Stream in 3Q17?.NEWS6: Eli Lilly CEO Says Drug Pricing Innovation Is Needed.NEWS7: Why AbbVie Is Focused on Expanding Risankizumab’s Label for Multiple Immunology Indications.NEWS8: Examining Incyte’s Quarterly Revenue Trend.NEWS9: Eli Lilly To Present At J.P. Morgan Healthcare Conference; Webcast At 7:00 PM ET.NEWS10: Eli Lilly To Present At J.P. Morgan Healthcare Conference; Webcast At 7:00 PM ET.NEWS11: FDA Approvals Surge in 2017: Here's a Look at the Numbers.NEWS12: The 1 Word That Explains Why Pfizer's Future Looks Brighter Than Its Past.NEWS13: Despite Setbacks, Drugmakers Have Plans to Fight Alzheimer’s.NEWS14: Drug Industry Isn't Giving Up on Alzheimer's.
2018-01-10: NEWS1: Eli Lilly & Co. at J.P. Morgan: 5 Things Investors Will Want to Know.NEWS2: Eli Lilly & Co. at J.P. Morgan: 5 Things Investors Will Want to Know.

Answer: Rise